Concepedia

Amelia S. George

AS

Statistics

Publications

5

Citations

2K

H-Index

5

Active since

2020

Affiliations

University of North Carolina at Chapel Hill(Current)

Vanderbilt University Medical Center

Gilead Sciences (United States)

Vanderbilt University

Amelia S. George is an author at University of North Carolina at Chapel Hill specializing in molecular virology, antiviral therapy, and sars-cov-2 infection.

ORCID

Publications per year

2020–2022

5

Publications

5

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

Timothy P. Sheahan, Amy Sims, Shuntai Zhou et al. · Science Translational Medicine · 2020 · 1.2K citations · Full text

, , +17

Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice

Andrea J. Pruijssers, Amelia S. George, Alexandra Schäfer et al. · Cell Reports · 2020 · 540 citations · Full text

, , +17

Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms

Laura J. Stevens, Andrea J. Pruijssers, Hery W. Lee et al. · Science Translational Medicine · 2022 · 252 citations · Full text

, , +17

Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice

Andrea J. Pruijssers, Amelia S. George, Alexandra Schäfer et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 36 citations · Full text

, , +17

Remdesivir Potently Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice

Andrea J. Pruijssers, Amelia S. George, Alexandra Schäfer et al. · SSRN Electronic Journal · 2020 · 22 citations · Full text

, , +17

1–5 of 5